The global healthcare contract development and manufacturing organization market size is expected to reach around US$ 456.8 billion by 2030 from US$ 224.57 billion in 2021 and is expected to grow at an impressive double-digit rate of 8.2% from 2022 to 2030.
The study includes drivers and restraints of this market. The study provides an analysis of the global healthcare contract development and manufacturing organization market for the period 2017-2030, wherein 2022 to 2030 is the forecast period and 2021 is considered as the base year.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 180+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2022 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
- Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download Free Sample Copy Here (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1615
Report Scope of the Healthcare Contract Development and Manufacturing Organization Market
| Report Coverage | Details |
| Market Size by 2030 | USD 456.8 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 8.2% |
| North America Market Share in 2021 | 41.5% |
| Contract Manufacturing Market Share in 2021 | 74% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
Research Methodology
A unique research methodology has been utilized to conduct comprehensive research on the growth of the global healthcare contract development and manufacturing organization market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the draw conclusions. Secondary sources referred to by analysts during the production of the global market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from mattress topper industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global healthcare contract development and manufacturing organization market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped to estimates the future prospects of the global market more reliable and accurate.
Why should you invest in this report?
If you are aiming to enter the global healthcare contract development and manufacturing organization market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for healthcare contract development and manufacturing organization are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030, so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Some of the prominent players in the global healthcare contract development and manufacturing organization market include:
- Flex
- Covance Inc.
- Lonza Group Ltd.
- Thermo Fisher Scientific Inc.
- Jabil
- Catalent Inc.
- Sanmina Corporation
- IQVIA Holdings Inc.
- Siegfried Holding AG
- Recipharm AB
Market Segmentation:
By Services
- Contract Manufacturing
- Small Molecule
- Preclinical
- Bioanalysis and DMPK studies
- Toxicology Testing
- Other Preclinical Services
- Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Laboratory Services
- Bioanalytical Services
- Analytical Services
- Preclinical
- Large Molecule
- Cell Line development
- Process Development
- Upstream
- Microbial
- Mammalian
- Others
- Downstream
- MABs
- Recombinant proteins
- Others
- Upstream
- Others
- Small Molecule
- Contract Development
- Small Molecule
- Large Molecule
- MABs
- Recombinant proteins
- Others
- High Potency API
- Finished Dose Formulations
- Solid Dose Formulation
- Liquid Dose Formulation
- Injectable Dose Formulation
- Medical Devices
- Class I
- Class II
- Class III
Regional Analysis:
The geographical analysis of the global healthcare contract development and manufacturing organization market has been done for North America, Europe, Asia-Pacific, and the Rest of the World.
The North American Market is again segmented into the US, Canada, and Mexico. Coming to the European Market, it can be segmented further into the UK, Germany, France, Italy, Spain, and the rest. Coming to the Asia-Pacific, the global healthcare contract development and manufacturing organization Market is segmented into China, India, Japan, and Rest of Asia Pacific. Among others, the market is segmented into the Middle East and Africa, (GCC, North Africa, South Africa and Rest of the Middle East & Africa).
Key Questions Answered by the Report:
- What will be the size of the global healthcare contract development and manufacturing organization market in 2030?
- What is the expected CAGR for the healthcare contract development and manufacturing organization market between 2021 and 2030?
- Which are the top players active in this global market?
- What are the key drivers of this global market?
- How will the market situation change in the coming years?
- Which region held the highest market share in this global market?
- What are the common business tactics adopted by players?
- What is the growth outlook of the global healthcare contract development and manufacturing organization market?
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Healthcare Contract Development and Manufacturing Organization Market
5.1. COVID-19 Landscape: Healthcare Contract Development and Manufacturing Organization Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Healthcare Contract Development and Manufacturing Organization Market, By Services
8.1. Healthcare Contract Development and Manufacturing Organization Market, by Services Type, 2020-2030
8.1.1. Contract Manufacturing
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Contract Development
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Healthcare Contract Development and Manufacturing Organization Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Services (2017-2030)
9.1.2. U.S.
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.2. UK
9.2.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.3. France
9.2.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.2.4. Rest of Europe
9.2.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.2. India
9.3.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.3. China
9.3.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.4. Japan
9.3.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.2. GCC
9.4.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.3. North Africa
9.4.3.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.4. South Africa
9.4.4.1. Market Revenue and Forecast, by Services (2017-2030)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.2. Brazil
9.5.2.1. Market Revenue and Forecast, by Services (2017-2030)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Forecast, by Services (2017-2030)
Chapter 10. Company Profiles
10.1. Flex
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Covance Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Lonza Group Ltd.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Thermo Fisher Scientific Inc.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Jabil
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Catalent Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Sanmina Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. IQVIA Holdings Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1615
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
0 Comments